Novartis AG is 51.8x more valuable than BELITE BIO, INC by market capitalization ($283.13 B vs $5.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BLTE | NVS |
|---|---|---|
| Market cap | $5.47 B | $283.13 B |
| US-listed rank | #1321 | #47 |
| Net income (latest FY) | -$77.61M | - |
| SEC filings | 194 | 947 |
Novartis AG is 51.8x more valuable than BELITE BIO, INC by market capitalization ($283.13 B vs $5.47 B).
Full pages: BELITE BIO, INC and Novartis AG, or browse the full rankings.